Piramal Pharma reports consolidated net profit of Rs. 153.50 crores in Q4 FY25

Piramal Pharma Limited has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 2796.10 crores during the period ended March 31, 2025 as compared to Rs. 2216.35 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 153.50 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 3.68 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 1.16 for the period ended March 31, 2025 as compared to Rs. 0.03 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹2796.10 crs	₹2216.35 crs	26.16%
Net Profit	₹153.50 crs	₹3.68 crs	4,071.20%
EPS	₹1.16	₹0.03	3,766.67%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs.2796.10 crores during the period ended March 31, 2025 as compared to Rs.2578.74 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.153.50 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.101.27 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.1.16 for the period ended March 31, 2025 as compared to Rs.0.77 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹2796.10 crs	₹2578.74 crs	8.43%
Net Profit	₹153.50 crs	₹101.27 crs	51.57%
EPS	₹1.16	₹0.77	50.65%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.9285.99 crores during the Financial Year ended March 31, 2025 as compared to Rs.8346.55 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.91.13 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.17.82 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.0.68 for the Financial Year ended March 31, 2025 as compared to Rs.0.14 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹9285.99 crs	₹8346.55 crs	11.26%
Net Profit	₹91.13 crs	₹17.82 crs	411.39%
EPS	₹0.68	₹0.14	385.71%

Shares of Piramal Pharma Limited was last trading in BSE at Rs. 219.00 as compared to the previous close of Rs. 214.90. The total number of shares traded during the day was 186054 in over 2629 trades.

The stock hit an intraday high of Rs. 219.95 and intraday low of 214.40. The net turnover during the day was Rs. 40490412.00.

Source : Equity Bulls

Keywords

PiramalPharma Q4FY25 Q4FY2025 FY2025 ResultUpdate